Tech Company Financing Transactions
Relypsa Funding Round
Relypsa, based in Redwood City, scored $49.7 million from private investors.
Transaction Overview
Company Name
Announced On
8/13/2012
Transaction Type
Venture Equity
Amount
$49,677,652
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
700 Saginaw Drive
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Orwin
Chief Financial Officer
Kristine Ball
VP - General Counsel
Ronald Krasnow
VP - Human Resources
Mary Corbett
VP - Regulatory Affairs
Claire Lockey
Browse more venture capital transactions:
Prev: 8/13/2012: Elcelyx Therapeutics venture capital transaction
Next: 8/13/2012: Stemgent venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs